Is Saxenda still relevant with newer GLP-1s available?

Yes. Saxenda is often preferred by plans due to longer market history and lower cost compared to Wegovy or Zepbound. Some patients also prefer daily injections for easier dose adjustments. If newer drugs were denied, Saxenda may be an approved alternative worth considering.

What BMI do I need for Saxenda coverage?

Most plans require BMI ≥30 kg/m² or BMI ≥27 kg/m² with at least one weight-related comorbidity. Saxenda appeals should include BMI documentation from multiple visits over time, showing chronic obesity rather than temporary weight gain.

Why does insurance prefer Saxenda over Wegovy?

Saxenda has been available since 2014 and is generally less expensive than Wegovy, which launched in 2021. Some plans tier medications by cost, requiring Saxenda trial before approving newer GLP-1s. This is standard step therapy protocol.

Do I need to document previous weight loss attempts?

Yes. Most plans require documentation of supervised weight loss attempts in the past 6-12 months, such as medically supervised diet programs, nutritionist visits, behavioral therapy, or previous weight loss medications. Include dates, durations, and outcomes.

Can I appeal if I had side effects from Saxenda?

Absolutely. Document specific side effects (nausea, vomiting, injection site reactions), their severity, duration, and impact on quality of life or medication adherence. Your doctor should note these in medical records and recommend an alternative GLP-1 with better tolerability.

What if Saxenda worked but my insurance stopped covering it?

This is a formulary change or non-medical switch. Appeal by documenting Saxenda's effectiveness (weight loss achieved, improved comorbidities, good tolerability) and negative consequences of switching to a different medication. Include your doctor's statement that changing working treatment is medically inappropriate.

Saxenda Insurance Appeal Guide

Placeholder content for Saxenda appeal guide.